IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q1 2022 Holdings

Filed 2022-05-16 | 5 holdings | $10.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Candel Therapeutics Inc(CADL)COM137404109$9.9M1,935,21598.2%
Dice Therapeutics IncCOM23345J104$63.0K3,292,8710.6%
Codex DNA IncCOM192003101$52.9K9,844,1300.5%
Isoplexis CorpCOM465005106$30.2K8,808,5310.3%
Vigil Neuroscience Inc(VIGL)COM92673K108$29.6K4,214,4980.3%